Literature DB >> 2493896

Lipid peroxides and atherosclerosis.

M D Stringer1, P G Görög, A Freeman, V V Kakkar.   

Abstract

Plasma lipid peroxide concentrations were measured in 100 patients with occlusive arterial disease proved angiographically (50 patients with ischaemic heart disease, 50 with peripheral arterial disease) and compared with values in 75 control patients with no clinical evidence of atherosclerosis. Lipid peroxide concentrations were significantly higher in patients both with ischaemic heart disease (median 4.37 mumol/l (interquartile range 3.85-5.75 mumol/l); p less than 0.001) and with peripheral arterial disease (median 4.37 mumol/l (3.88-5.21 mumol/l); p less than 0.001) than in controls (median 3.65 mumol/l (interquartile range 3.29-3.89 mumol/l). Overall there was a significant but weak correlation between plasma lipid peroxide and plasma triglyceride concentrations (rs = 0.25; p less than 0.001) but not between plasma lipid peroxide and plasma total cholesterol concentrations. Furthermore, hypertension, obesity, diabetes, smoking, positive family history, and intake of beta blockers and thiazide diuretics were not associated with significant differences in lipid peroxide values. This study provides clinical support to experimental data indicating that peroxidised lipids may be important in atherogenesis and its complications and also suggests that peroxidised lipids may provide an index of the severity of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493896      PMCID: PMC1835603          DOI: 10.1136/bmj.298.6669.281

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  21 in total

1.  Studies on the role of lipoperoxides in human pathology. II. The presence of peroxidized lipids in the atherosclerotic aorta.

Authors:  J GLAVIND; S HARTMANN; J CLEMMESEN; K E JESSEN; H DAM
Journal:  Acta Pathol Microbiol Scand       Date:  1952

2.  Lipid peroxide level in plasma of diabetic patients.

Authors:  Y Sato; N Hotta; N Sakamoto; S Matsuoka; N Ohishi; K Yagi
Journal:  Biochem Med       Date:  1979-02

3.  Prognostic significance of rheological and biochemical findings in patients with intermittent claudication.

Authors:  J A Dormandy; E Hoare; A H Khattab; D E Arrowsmith; T L Dormandy
Journal:  Br Med J       Date:  1973-12-08

Review 4.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

5.  The influence of diet-induced hypercholesterolemia on the degree of oxidation of glutathione in rabbit aorta.

Authors:  H Heinle; H Liebich
Journal:  Atherosclerosis       Date:  1980-12       Impact factor: 5.162

6.  Dietary supplementation with vitamin E in hyperlipoproteinemias: effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability.

Authors:  A Szczeklik; R J Gryglewski; B Domagala; R Dworski; M Basista
Journal:  Thromb Haemost       Date:  1985-08-30       Impact factor: 5.249

7.  Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic.

Authors:  M K Cathcart; D W Morel; G M Chisolm
Journal:  J Leukoc Biol       Date:  1985-08       Impact factor: 4.962

8.  Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages.

Authors:  A M Fogelman; I Shechter; J Seager; M Hokom; J S Child; P A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

9.  Low density lipoproteins (LDL) are carriers for lipid peroxides and inhibit prostacyclin (PGI2) biosynthesis in arteries.

Authors:  A Szczeklik; R J Gryglewski
Journal:  Artery       Date:  1980

10.  Lack of association between haemostatic variables and the presence or the extent of coronary atherosclerosis.

Authors:  U Schmitz-Huebner; S G Thompson; L Balleisen; C Fechtrup; W Grosse-Heitmeyer; B Kirchhof; E Most; U S Müller; C Seiffert; D Seiffert
Journal:  Br Heart J       Date:  1988-03
View more
  37 in total

1.  Low-density lipoproteins inhibit histamine and NaNO2 relaxations of the coronary vasculature and reduce contractile function in isolated rat hearts.

Authors:  G J Harrison; L R Jordan; M L Selley; R J Willis
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

2.  Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha.

Authors:  B M Kromer; J R Tippins
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Lipid peroxidation during myocardial ischaemia induced by pacing.

Authors:  K G Oldroyd; M Chopra; A C Rankin; J J Belch; S M Cobbe
Journal:  Br Heart J       Date:  1990-02

Review 4.  Vitamin E and cardiovascular disease.

Authors:  J Kleijnen; P Knipschild; G ter Riet
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 5.  Prospects for the use of antioxidant therapies.

Authors:  S R Maxwell
Journal:  Drugs       Date:  1995-03       Impact factor: 9.546

6.  Pregnancy induced hypertension: a role for peroxidation in microvillus plasma membranes.

Authors:  N Cester; R Staffolani; R A Rabini; R Magnanelli; E Salvolini; R Galassi; L Mazzanti; C Romanini
Journal:  Mol Cell Biochem       Date:  1994-02-23       Impact factor: 3.396

7.  Lipid peroxidation and antioxidant vitamins C and E in hypertensive patients.

Authors:  Y Wen; S Killalea; P McGettigan; J Feely
Journal:  Ir J Med Sci       Date:  1996 Jul-Sep       Impact factor: 1.568

Review 8.  Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus.

Authors:  K J Palmer; R N Brogden
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

9.  Reduced plasma fibrinogen, serum peroxides, lipids, and apolipoproteins after a 3-week vegetarian diet.

Authors:  A T Høstmark; E Lystad; O D Vellar; K Hovi; J E Berg
Journal:  Plant Foods Hum Nutr       Date:  1993-01       Impact factor: 3.921

10.  The role of selenium in the secretion of very-low-density lipoprotein in the isolated perfused rat liver.

Authors:  R L Scott; A Kheshti; M Heimberg; H G Wilcox; W L Stone
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.